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Abstract		The	 role	 of	 heterogeneous	 nuclear	 ribonucleoproteins	 (hnRNP)	 in	 cellular	senescence	 is	yet	 to	be	defined.	Cellular	 senescence	 is	a	 terminal	growth	arrest	 in	somatic	cells.		It	is	thought	to	be	the	consequence	of	telomeric	shortening	that	acts	as	 a	 DNA	 damage	 signal.	 	 Conversely,	 cells	 induced	 into	 premature	 senescence	(SIPS)	 by	 oxidative	 stress,	 is	 independent	 of	 telomere	 attrition.	 Premature	senescence	has	been	proposed	to	be	physiologically	relevant	as	it	can	be	induced	by	treatment	with	chemotherapeutic	agents.	In	particular,	we	are	studying	the	roles	of	hnRNP	A1	and	A2	 in	 the	maintenance	of	 the	senescence	phenotype.	hnRNPs	are	a	family	of	RNA	binding	proteins	that	play	key	roles	in	various	metabolic	functions	of	the	RNA	such	as	splicing.	hnRNP	A1	in	addition	to	its	biochemical	functions	in	RNA	metabolism	 can	 bind	 to	 mRNAs	 for	 transport	 through	 the	 nuclear	 envelope.	 Our	studies	have	shown	that	 the	protein	 level	of	hnRNP	A1	 is	 lower	 in	senescent	cells	
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than	 in	 young	 cells.	 Thus,	 we	 have	 hypothesized	 that	 the	 altered	 expression	 of	hnRNP	 A1	 potentially	 modulates	 gene	 expression	 profiles	 and	 may	 maintain	 the	senescent	phenotype.		We	have	observed	that	varying	the	levels	of	hnRNP	A1	alters	the	expression	levels	of	p21,	p16	and	ARF,	all	cell	cycle	regulators.	To	determine	if	this	 is	 the	 case	 during	 stress	 induced	 premature	 senescence	 (SIPS),	 IMR-90	fibroblast	diploid	normal	lung	cells	were	treated	with	a	sub-lethal	concentration	of	hydrogen	 peroxide	 that	 has	 been	 shown	 to	 induce	 premature	 senescence.	 To	determine	 if	hnRNPs	may	play	a	 role	 in	vivo,	we	measured	 their	 expression	 in	 rat	hippocampal	 lysates	 isolated	 from	 rats	 treated	 with	 a	 combination	 of	 the	chemotherapeutic	drugs,	doxorubicin	and	cyclophosphamide.	We	have	shown	here	that	 stress	 induced	 premature	 senescence	 is	 not	 modulated	 in	 the	 same	 hnRNP	dependent	fashion	as	replicative	senescence	and	possibly	independent	of	p38MAPK.		
		
Abreviations:		
SASP:	Senescence	associated	secretory	phenotype.		
SIPS:	Stress	Induced	pre-mature	senescence	
hnRNP:	Heterogeneous	ribonucleoprotein		
CDKN2A:	Cyclin	Dependent	Kinase	Inhibitor	2A	
PDL:	Population	doubling	level	
ROS:	Reactive	oxygen	species	
CICD:	Chemotherapy	induced	cognitive	decline	
	 1	
	
Introduction	
Cellular	senescence	and	aging.	As	humans	age,	we	become	increasingly	prone	to	developing	many	different	chronic	 multi	 system	 diseases.	 	 It	 is	 hypothesized	 that	 there	 are	 basic	 aging	processes	 that	 drive	 all	 of	 these	 different	 diseases	 and	 cellular	 senescence	 is	believed	to	be	one	of	the	major	basic	aging	processes	(Balducci	and	Ershler	2005).	Cellular	 senescence	 has	 been	 implicated	 in	 aging	 and	 degenerative	 age	 diseases.	Such	 diseases	 are	 neurodegeneration,	 muscular	 degeneration,	 osteoporosis,	sarcopenia	 as	 well	 as	 decreased	 kidney	 and	 lung	 function	 (Balducci	 and	 Ershler	2005,	Valko,	Leibfritz	et	al.	2007).	Cellular	 senescence	 is	 the	 halt	 of	 replication	 and	 the	 cell	 cycle	 in	 somatic	cells.	Once	a	 cell	becomes	senescent	 it	 can	 remain	active	 for	prolonged	periods	of	time,	however,	 they	cease	 to	respond	to	growth	 factors.	 	Replicative	senescence	 is	the	result	of	telomeric	shortening	and	the	resulting	DNA	damage.		In	contrast,	pre-mature	 senescent	 cells	 can	 be	 induced	 via	 various	 stress	 stimuli	 that	 can	 be	accomplished	by	the	exposure	to	producers	of	reactive	oxygen	species	(ROS)	such	as	hydrogen	peroxide	or	doxorubicin	(Kim,	Kim	et	al.	2006).	Hayflick	 and	 Moorhead	 described	 replicative	 senescence	 as	 the	 point	 at	which	 cells	 reach	 their	 terminal	 cell	 division	and	undergo	morphological	 changes.	This	morphology	 is	 irreversible,	 and	 the	 cells	 cease	 to	 respond	 to	 growth	 factors,	although	they	may	maintain	metabolic	activity	for	a	long	time	(Hayflick	1976).	
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The	 lifespan	of	 the	cells	 in	culture	 is	dependent	on	the	population	doubling	(PD)	 and	 not	 the	 time	 the	 cells	 have	 been	 cultured.	 This	 phenomenon	 has	 been	coined	the	Hayflick	limit.	Hayflick’s	work	has	correlated	with	other	studies	that	have	shown	 that	 as	 cells	 age	 and	 enter	 senescence,	 their	 telomeres	 are	 significantly	shortened	 (Hayflick	1976,	Rizvi,	Raza	 et	 al.	 2014).	Telomeres	 act	 as	 a	buffer	 zone	that	protects	the	chromosomes	from	degradation	and	fusion	to	other	chromosomes,	after	multiple	 replications.	 Interestingly	 enough,	many	 cancer	 cells	 do	 not	 exhibit	this	 decrease	 in	 telomere	 length,	 which	 has	 been	 attributed	 to	 a	 highly	 active	enzyme	called	telomerase	(Shay	and	Wright	2011,	Falandry,	Bonnefoy	et	al.	2014).		Senescent	 cell	 accumulation	has	been	observed	 in	almost	all	 vertebrates	as	the	 organism	 ages	 (Falandry,	 Bonnefoy	 et	 al.	 2014).	 Interestingly,	 age	 related	pathologies	 also	 correlate	with	 a	 local	 increase	 of	 senescent	 cells.	 Some	 examples	are	increased	senescence	associated	markers	present	in	endothelial	cells	at	the	base	of	 atherosclerotic	 plaque	 and	 senescent	 chondrocytes	 in	 arthritic	 joints	 (Coppe,	Desprez	 et	 al.	 2010).	 	 Accumulation	 is	 also	 present	 in	 degenerative	 diseases	 and	benign	prostatic	hyperplasia	(Castro,	Giri	et	al.	2003).		Senescence	 is	 seen	 as	 a	 response	 to	 stressors	 that	 result	 in	 a	 bipartite	phenotype.	 The	 two	 distinct	 models	 of	 this	 response	 are	 the	 irreversible	 growth	arrest	 and	 the	 presence	 of	 senescence	 associated	 secretory	 phenotype	 (SASP)	(Balducci	and	Ershler	2005).	 	The	 irreversible	cell	growth	arrest	 is	 the	 factor	 that	brings	 positive	 protections	 at	 young	 age,	 such	 as	 prevention	 of	malignant	 cancer	development	 and	 tissue	 remodeling.	 The	 SASP	 on	 the	 other	 hand	 can	 actually	become	maladaptive	by	driving	the	aging	process,	which	can	modulate	chronic	age	
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related	diseases(Acosta,	O'Loghlen	et	al.	2008).	The	stressors	that	can	induce	these	two	 phenotypes	 are	 vast	 and	 include	 genomic	 damage,	 metabolic	 stress	 and	organelle	stress	(Campisi	2005).	Despite	there	being	no	specific	cellular	senescence	marker	and	we	rely	on	a	number	of	different	marker	together	such	as	increased	ROS	production,	 SA-ß-gal,	 increased	p16ink4a,	 and	 SASP,	which	 are	 discussed	 in	more	detail	later	on	in	this	paper.		Most	 of	 the	 common	 chronic	 age	 related	 pathologies	 have	 an	 increased	amount	 of	 inflammation	 and	 are	 thought	 to	 be	 the	 result	 of	 senescent	 cell	accumulation	 (Cevenini,	 Caruso	 et	 al.	 2010,	 Freund,	 Orjalo	 et	 al.	 2010).	 The	senescent	 associated	 secretory	 phenotype	 is	 a	 collection	 of	 forty	 different	chemokines,	cytokines	and	proteases	that	are	the	main	modulators	of	inflammation	(Coppe,	 Desprez	 et	 al.	 2010).	 In	 addition,	 HMGB1,	 a	 protein	 that	 is	 usually	 only	found	in	the	nucleus	is	excreted	by	senescent	cells.	In	the	nucleus,	HMGB1	organizes	DNA	and	prepares	it	for	transcription	but	in	SASP	and	immune	cells	it	can	act	as	a	cytokine	mediator	of	inflammation	(Wang,	Bloom	et	al.	1999).		Cells	possessing	SASP	have	potent	paracrine	activity,	which	can	influence	the	differentiation	 and	 organization	 of	 neighboring	 cells.	 This	 was	 shown	 in	 3D	mammary	 epithelial	 organoid	 β-casein	 producing	 culture.	 When	 senescent	 cells	were	 introduced	 into	 the	 culture	 with	 normal	 mammary	 cells,	 cells	 lost	 their	previously	 observed	 alveoli	 structure	 and	 the	 production	 of	 the	 β-casein	significantly	decreased	(Parrinello,	Coppe	et	al.	2005).			 Senescent	cells	also	have	the	ability	to	induce	proliferation	and	angiogenesis	in	preneoplastic	cells	in	culture	(Krtolica,	Parrinello	et	al.	2001).	This	has	also	been	
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observed	 in	 vivo	 with	 mice	 that	 were	 injected	 with	 preneoplastic	 cells	 do	 not	develop	a	tumor	(Krtolica,	Parrinello	et	al.	2001).	However,	once	mice	were	injected	with	 senescent	 cells	 the	 preneoplastic	 cells	 transformed	 into	 large	 vascularized	tumors.	Interestingly,	senescent	cells	are	important	for	wound	healing.	The	creation	of	a	wound	senescent	cells	increase	locally	for	a	short	period	of	time	and	over	time	die	 resulting	 in	 undetectable	 number,	 usually	 after	 8	 days	 (Laberge,	 Adler	 et	 al.	2013).	The	cells	are	primarily	endothelial	and	fibroblast.	Ganciclovir	 is	a	drug	that	can	kill	non-dividing	senescent	cells	by	damaging	mitochondrial	DNA	via	apoptosis	(Laberge,	Adler	et	al.	2013).	When	mice	were	treated	with	Ganciclovir,	 the	wound	healing	response	was	drastically	hindered	Demaria,	Ohtani	et	al.	(2014)	identified	a	growth	 factor	 secreted	 by	 senescent	 cells	 called	 PDGF-A	 that	was	 present	 during	wound	 healing,	 and	 most	 importantly	 this	 growth	 factor	 was	 able	 to	 rescue	 the	wound	healing	response	in	Ganciclovir	treated	cells.		Given	this	a	paradox	arises:	why	does	wound	healing	become	worse	with	age	when	 the	 amount	 of	 senescent	 cells	 increases	 with	 age	 (Keyes,	 Liu	 et	 al.	 2016)?	Interestingly,	with	age	the	innate	antioxidant	capabilities	of	cells	decreases	resulting	in	 oxidative	 stress	 and	 therefore	 induces	 a	 chronic	 presence	 of	 senescent	 cells,	instead	of	a	transient	presence	as	we	see	in	young	wound	healing	(Velarde,	Flynn	et	al.	2012)	.	Senescence	 also	 proves	 to	 be	 relevant	 in	 post	 chemotherapy	 treatment	patient	 outcomes.	 Chemotherapeutic	 regiments	 with	 ionizing	 radiation	 (IR),	doxorubicin	and	phosphomide,	to	name	a	few,	are	all	genotoxic	and	will	result	in	an	
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increased	 amount	 of	 cells	 positive	 for	 senescent	markers.	 (Demaria,	 Ohtani	 et	 al.	2014).		In	 a	 longitudinal	 study	 that	 tracked	 childhood	 cancer	 survivor’s	 health	records,		has	shown	that	once	these	patients	reach	the	age	of	forty	five	they	have	a	statistically	significant	prevalence	of	age	related	degenerative	diseases	usually	seen	in	 much	 older	 populations	 (Hudson,	 Ness	 et	 al.	 2013)	 .These	 diseases	 included	musculoskeletal,	 reproductive,	 hepatic,	 renal	 and	 neurocognitive	 dysfunctions,	 to	name	a	few.	We	have	also	shown	that	a	chemotherapy	cocktail	of	doxorubicin	and	cyclophosphamide	cause	neurodegenerative	phenotype.	 	 	Female	rats	 treated	with	this	regiment	exhibited	a	significantly	impaired	working	and	special	memory	(Salas-Ramirez,	Bagnall	et	al.	2015).		Baker,	 Wijshake	 et	 al.	 (2011)	 has	 shown	 that	 transgenic	 mice	 lacking	p16Ink4a-positive	 senescent	 cells	 have	 an	 increased	 resistance	 to	 previously	mentioned	 age	 associated	 disorders.	 Senescent	 cells	 have	 the	 ability	 to	 suppress	tumor	proliferation	(Burton	and	Krizhanovsky	2014).	An	example	are	a	hyperplastic	legions	such	as	melanocytic	nevi	are	melanocytes	that	have	undergone	senescence	
in-vivo	due	to	activation	of	the	BRAF	oncogene	(Joselow,	Lynn	et	al.	2017).	Sub	 lethal	 concentration	 of	 oxidative	 stress	 causing	 agents	 can	 be	 used	 to	induce	a	SIPS	phenotype	(Frippiat,	Dewelle	et	al.	2002,	Wang,	Wei	et	al.	2013),	and	therefore	possibly	a	useful	model	 to	 study	 replicative	 senescence.	 	Both	SIPS	cells	and	 replicative	 senescent	 cells	 exhibit	 a	 unique	morphological	 state;	 they	 become	large	 and	 flat,	 and	 have	 an	 increase	 SA	 ß-galactosidase	 activity	 (Dimri,	 Lee	 et	 al.	1995,	Krishna,	Sperker	et	al.	1999).	SIPS	fibroblast	cells	produce	a	high	amount	of	
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reactive	oxygen	 species	 like	H2O2	 and	 contain	30%	more	8-oxo-2-deoxyguanosine	DNA	 (Fleming,	 Muller	 et	 al.	 2011).	 Furthermore	 they	 accumulate	 oxidative	 DNA	damage	based	on	the	increased	amount	of	free	guanosine	bases	(Kino,	Hirao-Suzuki	et	al.	2017).	
Oxidative	damage	It	 has	 been	 proposed	 that	 normal	 aging	 is	 the	 result	 of	 accumulation	 of	oxidative	 stress	 from	 reactive	 oxygen	 species	 (ROS)	 (Squier	 2001).	 ROS	 are	produced	during	normal	cellular	processes	and	metabolism.	ROS	production	can	be	the	 result	 of	 exposure	 to	 sub-lethal	 amounts	 of	 heat,	 ultraviolet	 light,	chemotherapeutic	 drugs,	 radiation	 and	 even	 phagocytic	 leukocytes	 (Robinson	2008).		The	accumulation	of	tissue	damage,	specifically	due	to	ROS,	is	considered	to	be	the	root	cause	of	the	aging	process.	As	previously	mentioned,	DNA	is	negatively	impacted	 by	 ROS	 resulting	 in	 many	 different	 lesions	 such	 as	 base	 modifications,	strand	 breaks	 and	 cross-linking.	 Similar	 to	 what	 occurs	 in	 tissue	 culture,	 the	accumulation	of	of	8-oxo-2-deoxyguanosine	DNA	 in	aging	 individuals’	 increases	 in	part	due	to	a	decreased	ability	to	repair	the	damage	(Kaneko,	Tahara	et	al.	2003).	It	is	worth	mentioning	 that	ROS	does	not	 only	 affect	DNA,	but	 also	 causes	oxidative	damage	 to	 proteins	 and	 lipids	which	 result	 in	 pathologies	 such	 as	 cardiovascular	disease	(Panth,	Paudel	et	al.	2016).			ROS	containing	superoxide	radical	anion,	O2	̇,	and	hydroxyl	radical,	OH	̇,	are	produced	 during	 normal	 metabolic	 activity	 in	 the	 mitochondria	 of	 living	 cells	(Cadenas	and	Davies	2000).	During	cellular	 respiration	Cytochromes	P450	readily	convert	 diatomic	 oxygen	 to	 O2	̇,	 which	 is	 then	 converted	 to	 hydrogen	 peroxide	
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(Karuzina	and	Archakov	1994).	The	amount	of	hydrogen	peroxide	is	generally	kept	at	 low	 levels,	 and	 is	 efficiently	 converted	 to	 non-toxic	 compounds	 like	 water.		However,	certain	conditions	such	as	the	presence	of	transitions	metals,	resulting	in	the	 Fenton	 reaction	 and	 the	 exposure	 to	 UV	 radiation	 causing	 photolysis	 of	hydrogen	 peroxide	 can	 increase	 the	 amount	 of	 hydroxyl	 radicals	 significantly	(Panth,	Paudel	et	al.	2016).	The	resulting	DNA	damage	accumulation	in	the	cells	may	induce	them	to	become	prematurely	senescent	independent	of	telomere	shortening	through	 intracellular	 signaling	 molecules	 regulating	 kinase-driven	 pathways	(Chang,	Broude	et	al.	1999).	Also,	naturally	produced	one-electron	free	radicals	can	react	 with	 certain	 parts	 of	 the	 DNA,	 often	 guanine,	 and	 cause	 errors	 and	modifications	 (Panth,	 Paudel	 et	 al.	 2016).	 	 It	 has	 also	 been	 shown	 that	 levels	 of	mitochondria	derived	hydrogen	peroxide	 are	 increased	 in	 aging	 fly	models	 (Sohal	and	Sohal	1991).	
Heterogeneous	nuclear	ribonucleoproteins	(hnRNPs)		 Heterogeneous	 nuclear	 ribonucleoproteins	(hnRNPs)	 are	 a	 vast	 family	 of	RNA	binding	proteins	(RBPs)	 that	are	 the	most	abundant	of	all	eukaryotic	nuclear	proteins	 and	 ranging	 in	 size	 from	 34	 to	 120	 kDA	 (Pinol-Roma,	 Choi	 et	 al.	 1988).	Post-transcriptional	modifications	directed	by	RNA	binding	proteins	(RBPs)	play	a	key	 role	 in	 the	 maturation	 of	 nascent	 RNA.	 hnRNPs	 process	 the	 hnRNA	 though	capping,	polyadenilation,	splicing,	and	shuttling	the	pre-mRNA	between	the	nucleus	and	cytoplasm	(Pinol-Roma,	Choi	et	al.	1988,	Krecic	and	Swanson	1999).	Despite	the	diversity	 of	 hnRNPs	 they	 contain	many	 highly	 conserved	 RNA	 recognition	motifs	(RRM).	These	motifs,	such	as	the	UP1	region	in	hnRNP	A1,	play	a	crucial	role	in	RNA	
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binding	 that	 is	 responsible	 for	 telomere	 regulation	 and	 splicing	 (Xu,	 Jokhan	 et	 al.	1997).		 Currently	 over	 twenty	different	 hnRNPs	 are	 known	 to	 exist	 in	 the	nucleus,	including	hnRNP	A1,	A2/B1,	C1/C2	and	K	(Krecic	and	Swanson	1999).	In	eukaryotic	cells,	 hnRNPs	 are	 part	 of	 the	 RNA	 polymerase	 II	machinery	 and	 the	 nascent	 RNA	binds	 them	 immediately(McCloskey,	 Taniguchi	 et	 al.	 2012).	 This	 RNA	 –	 hnRNP	complex	remains	bound	through	the	maturation	of	the	RNA	and	up	to	the	point	the	RNA	 is	 transported	out	 of	 the	nucleus	 (Dreyfuss,	Matunis	 et	 al.	 1993).	 hnRNP	A1,	A2/B1	and	K	are	known	to	shuttle	between	the	nucleus	and	the	cytoplasm,	and	are	involved	in	different	cell	processes.	hnRNP	A1	and	A2/B1	in	particular,	are	though	to	play	a	key	role	in	cell	proliferation	and	survival	(He,	Brown	et	al.	2005).	The	hnRNP	A2/B1	protein	plays	an	important	role	in	the	correct	localization	of	transcripts	that	contain	the	A2	response	element	or	A2RE	(Shan,	Moran-Jones	et	al.	 2000).	 This	 interaction	 modulates	 the	 correct	 localization	 of	 transcripts	 that	contain	the	A2RE	in	oligodendrocytic	and	neuronal	mRNA	(Shan,	Munro	et	al.	2003).	Increased	 levels	 of	 intracellular	 amount	 of	 Ca2+	 have	 been	 shown	 to	 promote	 the	A2RE	interaction	with	hnRNP	A2/B1	(Muslimov,	Tuzhilin	et	al.	2014).	Interestingly,	it	has	been	shown	that	stress	induced	senescence	and	oxidative	stress	 increases	 the	 level	 calcium	present	 in	 the	 cell	derived	 from	 the	ER	 through	the	phospholipase	C,	IP3,	and	IP3R	pathway	(Borodkina,	Shatrova	et	al.	2016).	The	increase	in	calcium	ions	may	affect	neuronal	activity	by	altering	the	hnRNP	A2/B1	interaction	 with	 A2RE.	 It	 has	 been	 suggested	 that	 oxidative	 stress	 may	 lead	 to	various	neurodegenerative	pathologies	(Valko,	Leibfritz	et	al.	2007).	
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Cell	Cycle	regulators	and	the	role	of	hnRNPs	During	normal	 cellular	 growth	 and	division,	 the	 cell	 goes	 through	 four	 key	regulatory	stages:	preparation	 for	DNA	synthesis	and	checking	 for	errors,	G1;DNA	synthesis,	S;	the	final	check	of	the	DNA	for	damage	and	preparation	for	mitosis,	G2;	and	finally	the		completion	of	the	cell	cycle	resulting	in	production	of	two	daughter	cells	 via	 mitosis	 (Selvarajah,	 Elia	 et	 al.	 2015).	 With	 necessary	 growth	 factors	available	to	the	cell,	it	may	continue	to	undergo	mitosis	until	the	terminal	division	or	exit	 the	 cell	 cycle	 and	 enter	 a	 non-dividing	 state	 called	 G0	 (Marcotte	 and	 Wang	2002).	 Cells	 can	 also	 be	 in	 a	 sub	 G0	 pseudo	 stage	 where	 DNA	 is	 becoming	fragmented	due	to	the	onset	of	apoptosis	(Newbold,	Martin	et	al.	2014).	In	contrast	to	actively	dividing	cells,	senescent	cells	do	not	enter	the	S	phase	in	 order	 to	 prevent	 possible	 faulty	 or	 incomplete	 genetic	 information	 from	replicating,	usually	arresting	in	G1	or	G2	after	reaching	their	terminal	division	(Mao,	Ke	 et	 al.	 2012).	 In	 addition,	 senescent	 cells	 become	 phenotypically	 different	 from	their	younger	counterparts.	Senescent	cells	become	larger	in	size	with	a	visibly	flat	and	 spread-out	 appearance	 (Marcotte	 and	 Wang	 2002).	 During	 this	 transition,	 a	host	of	molecular	changes	occur,	many	of	which	are	yet	to	be	elucidated.	Some	key	molecular	changes	can	be	seen	in	the	cell	cycle	regulatory	proteins	such	as	cyclins	and	cyclin	dependent	kinases	(cdK’s)	(Capparelli,	Chiavarina	et	al.	2012).	The	levels	of	these	cells	cycle	regulators,	specifically	those	present	at	G1	and	G2,	are	severely	down	regulated	or	nonexistent	in	senescent	cells	(Zhu	et	al	.,	2002).		This	 is	 most	 likely	 attributed	 to	 the	 over	 expression	 of	 cdK	 inbibitors	 in	senescent	cells,	such	as	p21,	p14,	p16	and	p53	(Capparelli	et	al	 .,	2012).	Senescent	
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cells	have	an	increased	expression	of	various	lysozomal	enzymes,	particularly	a	pH	neutral	 senesce	 associated	 biomarker	 ß-galacotosidase	 (SAß-Gal)	 (Krishna	 et	 al	 .,	1999).	This	marker	is	expressed	by	senescent	and	prematurely	senescent	cells,	but	is	not	present	in	pre-senescent	quiescent	cells.	SAß-Gal	assay	can	therefore	be	used	to	 verify	 the	 presence	 of	 senescent	 cells	 (Dimri,	 Lee	 et	 al.	 1995).	 When	 normal	human	diploid	fibroblast	cells	are	exposed	to	oxidative	stress	they	begin	to	exhibit	a	stress	induced	premature	senescence	(SIPS)	(Chen,	Bartholomew	et	al.	1998).	One	 of	 the	 most	 important	 cell	 cycle	regulators	 that	 controls	 tumor	 suppression	 is	 p53	(Vogelstein,	 Lane	 et	 al.	 2000).	Normal	 healthy	 cells	maintain	 low	 levels	 of	 p53	 through	 negative	regulation	 of	 MDM2,	 which	 forms	 a	 complex	 with	p53	 at	 the	 transcription	 activation	 domain.	 When	the	 MDM2-p53	 complex	 forms,	 p53	 loses	 its	transcription	 factor	 function	 while	 simultaneously	being	 marked	 for	 degradation	 (Vogelstein,	 Lane	 et	al.	2000).	When	cells	experience	stressors	such	as	DNA	damage	via	 the	activation	of	 cell	 cycle	inhibitors,	 the	MDM2-p53	 complex	 is	 severed.	Now	free	p53	is	not	being	actively	degraded	and	its	transcription	activation	site	 is	available	(Wei,	Hemmer	et	al.	2001).	The	increase	in	p53	levels	and	activity	causes	multiple	different	phenotypes	such	as	cell	cycle	arrest	and	apoptosis.	p53	can	cause	the	upregulation	of	both	upstream	and	downstream	cell	cycle	and	survival	signals	
Figure	1.	Summary	of	p53-p21	and	p16-Rb	stress	induced	senescence	pathways	in	mammalian	fibroblasts	models.		
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(D'Orazi,	Cecchinelli	et	al.	2002).	The	full	mechanism	of	this	regulation	is	yet	to	be	understood,	but	it	known	to	regulate	the	biological	response	and	the	fate	of	the	cell.		Both	p14ARF	and	p16INK4	play	key	roles	in	modulating	replicative	senescent	phenotype	and	are	key	cell	cycle	regulators	(Sharpless	and	DePinho	1999).		As	seen	in	Figure	1,	 p14ARF	works	by	 inhibiting	MDMD2,	 resulting	 in	 an	 activation	of	 p53,	which	 can	 then	 induce	p21	 expression,	 and	 therefore	 inactivating	CDK	 complexes	responsible	 for	 transcription	 of	 genes	 active	 during	 G1	 stage	 of	 the	 cell	 cycle	(O'Connor	1997).	Alternatively,	cells	that	exhibit	phosphorylation	of	cdc2	mediated	cellular	which	result	in	a	G2	cell	cycle	arrest	(Poon,	Jiang	et	al.	1996).		When	 hnRNP	 A1	 and	 A2	were	 overexpressed,	 this	 resulted	 in	 a	 change	 in	splicing	(Zhu,	Xu	et	al.	2002).	The	CDKN2A	gene	contains	two	mRNA	targets,	p14ARF	and	p16INK4a,	 that	are	 important	 for	senescence.	 	The	overexpression	of	hnRNP	A1	and	A2	promoted	 the	 use	 of	 distal	 splice	 sites	 and	 loss	 of	 certain	 exons	 (Mayeda,	Helfman	et	al.	1993).		This	resulted	in	the	production	of	more	p14ARF	splice	variants	of	the	CDKN2A	gene.		The	over	expression	of	both	hnRNP	A1	and	A2	increased	the	ratio	 of	 p14ARF	 to	 p16INK4a.	 These	 observations	 indicate	 that	 hnRNP	 A1	 and	 A2	binding	 might	 be	 moderating	 the	 expression	 of	 the	 above	 mentioned	 ell	 cycle	regulators.	 During	 replicative	 senescence	 hnRNP	 A1	 and	 A2	 and	 C1/C2	 protein	expression	decreases	in	normal	human	fibroblast	cells	and	an	increased	amount	of	p16INK4a	has	been	observed	(Hubbard,	Dhanaraj	et	al.	1995,	Wang,	Wu	et	al.	2001).	In	 addition,	 we	 have	 shown	 that	 the	 ratio	 of	 p14ARF	 to	 p16INK4a	 mRNA	 is	directly	related	to	the	expression	of	hnRNP	A1	and	A2	(Zhu,	Xu	et	al.	2002).	Given	that	senescent	cells	exhibit	lower	levels	of	hnRNP	A1	and	A2	(Hubbard,	Dhanaraj	et	
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al.	 1995),	 it	 is	 thought	 that	p16INK4a	levels	will	be	higher	then	p14ARF.	Therefore,	 it	was	hypothesized	that	hnRNP	A1	and	A2	were	able	to	modulate	the	gene	expression	through	 alternative	 splicing	 of	 cell	 cycle	 regulators	 that	 maintain	 the	 replicative	senescence	phenotype.		In	 addition	 to	 the	 decreased	 expression	 of	 hnRNPs	 in	 senescent	 fibroblast	cells,	 we	 have	 shown	 that	 hnRNP	 A1	 and	 A2	 accumulates	 in	 the	 cytoplasm	 of	senescent	(Shimada,	Rios	et	al.	2009,	Capparelli,	Chiavarina	et	al.	2012).	In	contrast,	hnRNP	A1	and	A2	are	 localized	 in	the	nucleus	 in	proliferative	cells	and	G0	growth	arrested	cells.	It	has	been	suggested	that	accumulation	in	the	cytoplasm	is	the	result	of	 hnNRPs	 being	 phosphorylated	 (van	 der	 Houven	 van	 Oordt,	 Diaz-Meco	 et	 al.	2000).	 Senescent	 cells	 have	 been	 shown	 to	 have	 an	 increase	 in	 p-38	 MAPK	expression	 which	 interacts	 with	 hnRNP	 A1	 (Shimada,	 Rios	 et	 al.	 2009,	 Ziaei,	Shimada	et	al.	2012).		Inhibition	of	p-38	MAPK	activity	resulted	in	an	increase	in	hnRNP	A1	levels,	the	 same	 however	 was	 not	 observed	 for	 hnRNP	 A2.	 The	 accumulation	 in	 the	cytoplasm	of	these	crucial	RBPs	may	in	part	impact	the	stability	of	various	mRNAs	(Shimada,	Rios	et	al.	2009,	Ziaei,	Shimada	et	al.	2012).	It	has	also	been	shown	that	when	 hnRNP	A1	 and	A2	were	 knocked	 out	 via	 siRNA,	 this	 induced	 the	 senescent	phenotype	 (increased	 F-actin	 and	 larger	 cell	 morphology).	 Therefore,	 it	 was	proposed	 that	 hnRNP	 A1	 is	 regulated	 in	 part	 via	 p-38	 MAPK	 phosphorylation	 to	partially	maintain	the	senescent	phenotype	(Hubbard,	Dhanaraj	et	al.	1995,	Zhu,	Xu	et	al.	2002,	Shimada,	Rios	et	al.	2009).	
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Another	major	RBP,	hnRNP-K,	binds	to	cysteine	rich	regions,	plays	a	key	role	in	p53	DNA	damage	response	and	cellular	arrest	 in	 the	G1/G2	stages.	hnRNP	K	 is	inducted	by	the	inhibition	of	the	Ubiquitin	E3	ligase	MDM2	(or	HDM2).	It	has	been	shown	 that	hnRNP	K	 siRNA	results	 in	a	decreased	expression	of	p53	 target	genes	and	a	resulting	defective	DNA	damage	response	(Moumen,	Masterson	et	al.	2005).	DNA	damage	via	UV	and	IR	radiation	has	shown	to	increase	the	levels	of	hnRNP	K	in	fibroblast	 cells	 (Moumen,	Masterson	 et	 al.	 2005).	 It	was	 also	 shown	 that	 levels	 of	hnRNP-K	are	 low	 in	normal	 fibroblast	 cells	and	are	 increased	 in	 tumorigenic	 cells	(Gao,	 Yu	 et	 al.	 2013).	 This	 RNA	 binding	 protein	 may	 have	 a	 role	 in	 modulating	premature	senescence	and	senescent	like	phenotypes	in	a	novel	way	different	from	hnRNP	A1	and	A2.	Since	we	have	shown	that	the	levels	of	some	hnRNPs	in	replicative	senescent	cells	are	diminished	it	is	of	interest	to	know	whether	the	same	trend	holds	true	with	pre-mature	senescent	cells.	This	is	relevant	because	some	chemotherapeutic	agents	such	as	doxorubicin	induce	oxidative	stress	to	control	tumor	proliferation	(Kim,	Kim	et	 al.	 2006).	 Others	 and	 we	 have	 shown	 that	 chemotherapeutics	 drugs	 such	 as	doxorubicin	 and	 cyclophosphamide	 induce	 cognitive	 dysfunction	 or	 CICD	 (Salas-Ramirez,	 Bagnall	 et	 al.	 2015).	 It	 has	 been	 proposed	 that	 CICD	 is	 the	 result	 of	oxidative	 stress	 induced	 by	 chemotherapeutic	 agents	 (Ahles	 and	 Root	 2018,	Moruno-Manchon,	Uzor	et	al.	2018).	Therefore,	we	have	examined	hnRNP	levels	in	pre-mature	senescent	cells	and	in	the	hippocampus	brain	region	of	rats	treated	with	doxorubicin	and	cyclophosphamide	chemotherapy	cocktail.	 	Given	 these	drugs	are	meant	to	halt	the	progression	of	tumorigenesis	partly	through	oxidative	stress,	it	is	
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possible	 that	 hnRNP	 A1,	 A2	 and	 K	 may	 modulate	 the	 induction	 of	 premature	senescence	in	cancer	cells.	 	
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Methods	
Cell	culture	
IMR-90	Cell	Culture	Early	 passage	 IMR	 90	 human	 diploid	 fibroblast	 cells	 were	 sub-cultured	 in	complete	media	 consisting	 of	 Dulbecco’s	 Modification	 of	 Eagles	 Medium	 (DMEM)	and	 F12	 in	 a	 1:1	 mixture	 (Gibco).	 The	 media	 was	 supplemented	 with	 10%	 fetal	bovine	serum	(Gibco)	and	1%	penicillin	streptomycin	(Gibco).		 The	 cultures	 were	 incubated	 and	 maintained	 at	 37ºC,	 in	 5%	 CO2	with	 the	media	 being	 changed	 three	 times	 per	 week.	 When	 the	 cells	 became	 above	 80%	confluent	 they	would	be	harvested	using	0.25%	 trypsin-EDTA	 (Life	Technologies)	and	 seeded	 on	 polystyrene	 tissue	 treated	 culture	 plates	 (Fisher	 Scientific)	 at	 a	density	of	1x106	cells	per	100mm2.	
Premature	senescent	cell	preparation	A	 stock	 solution	 of	 ACS	 30%	 hydrogen	 peroxide	 (Fisher	 Scientific)	 was	diluted	 to	 an	 initial	 stock	 dilution	 of	 1M	 using	 sterile	 deionized	 water.	 Working	solutions	 of	 150uM	 hydrogen	 peroxide	 were	 prepared	 using	 growth	 media	immediately	before	treatment	of	cells	under	a	biological	hood	and	sterile	conditions.	Cells	were	incubated	with	fresh	media	and	150uM	of	hydrogen	peroxide	for	2	hours	and	 then	 the	 media	 was	 changed.	 Cells	 were	 then	 treated	 again	 the	 next	 day	 to	ensure	cell	cycle	arrest.	Cells	were	then	allowed	to	recover	for	48	hours	and	the	cell	morphology	and	population	growth	was	observed.	
	 16	
Senescence	Associated	β	-Galactosidase	assay	(SA-	β	-Gal)		 The	culture	media	was	removed	from	IMR	90	cell	cultures.	The	cultures	were	washed	 with	 PBS,	 fixed	 with	 4%	 paraformaldehyde	 for	 10	 minutes	 at	 room	temperature	and	washed	three	times	in	PBS	to	remove	all	fixative.	Cells	were	then	incubated	with	a	staining	solution	(0.2M	citric	acid	sodium	phosphate	buffer	(pH	6),	100	 mM	 potassium	 ferrocyanide,	 100mM	 potassium	 ferricyanide,	 5M	 NaCl,	 1M	mgCl2	with	20	mg/mL	of	X-gal	dissolved	in	dimethylformamide	[DMF])	for	24	hours	at	37ºC	without	CO2..	Staining	observed	confirms	induction	of	senescence.	Ten	fields	were	counted	to	quantify	the	senescent	positive	cells.		
Cell	Cycle	profile			 The	 cell	 cycle	 profile	 of	 IMR	 90	 normal	 human	 fibroblast	 cells	 cultured	 in	complete	DMEM	medium	containing	hydrogen	peroxide	 for	4	hours	was	 analyzed	using	a	flow	cytometer.	Total	DNA	was	stained	using	FxCycle	Violet	dye	(Invitrogen)	and	the	DNA	staining	intensity	was	detected	with	a	DB	LSR	II	flow	cytometer	excited	with	a	405	nm	laser.	Data	analyses	were	conducted	using	BD	FACSDiva	8.0.2.	
Protein	sample	isolation			 Culture	media	was	aspirated	 from	IMR	90	cultures,	and	then	the	cells	were	washed	 with	 phosphate	 buffered	 saline	 (PBS	 pH	 7.4).	 Protein	 lysates	 were	 also	isolated	from	the	hippocampus	of	rats	treated	with	either	chemotherapy	or	saline.	The	description	of	how	the	rats	were	treated	is	described	in	detail	in	Salas-Ramirez,	Bagnall	et	al.	(2015)	.Then	ice	cold	RIPA	Lysis	buffer	(Thermo	Scientific)	was	added	to	the	plate.	Cells	were	harvested	using	a	cell	scraper	and	transferred	into	a	micro	
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centrifuge	 tube.	 Sample	 lysates	 were	 homogenized	 using	 a	 25-gauge	 needle	 and	then	centrifuged	at	14,000	x	g	for	20	minutes	at	4ºC.	
Western	Immunoblotting	Protein	 lysates	 were	 mixed	 with	 a	 reducing	 Laemelli	 sample	 buffer	containing	 β-mercaptoethanol	 and	 subsequently	 heated	 to	 95ºC	 for	 5	 minutes.	Protein	samples	were	separated	on	a	10%	polyacrylamide	gel	using	a	Mini-Protean	II	 system	 (BioRad)	 and	 then	 were	 transferred	 onto	 an	 Immobilon-FL	 PVDF	Membrane	0.45	µm	(Millipore)	at	100	volts	 for	45	minutes.	Following	the	transfer	the	membranes	were	 analyzed	 using	 either	 a	 Li-Cor	Odyssey	 scanner	 or	 ECL	 film	detection.	
Li-Cor	Odyssey	detection			 Membranes	were	initially	blocked	for	1	hour	in	Odyssey	tris	buffered	saline	(TBS)	 blocking	 buffer	 (Li-Cor)	 according	 to	 the	 manufacturers	 protocol.	 Then	membranes	 were	 incubated	 in	 the	 primary	 antibody	 overnight	 at	 4ºC	 and	 then	washed	three	times	in	TBS-T.	Primary	antibodies	were	detected	using	anti-mouse	IR	Dye680	 or	 anti-rabbit	 IR	 Dye800	 (Li-Cor)	 conjugated	 antibodies.	 The	membranes	were	incubated	in	the	secondary	antibody	solution	as	per	manufacturer	instructions	for	1	hour	at	room	temperature.	Following	the	incubation,	membranes	were	washed	as	 described	 above	 and	 detected	 using	 the	 Odyssey	 Imaging	 System	 (Li-Cor)	 by	quantifying	 the	 Integrated	 Intensities	 (II	 K	 counts).	 A	 student	 t-test	 was	 used	 to	analyze	the	data.		
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Enhanced	Chemiluminescence	detection		 The	membranes	initially	 for	1	hour	in	5%	skim	milk	made	diluted	in	TBS-T	for	1	hour	at	 room	 temperature.	Then	membranes	were	 incubated	 in	 the	primary	antibody	overnight	at	4ºC.		Following	primary	incubation,	membranes	were	washed	three	 times	 and	 incubated	 for	 1	 hour	 in	 a	 secondary	 horseradish	 peroxidase	conjugated	 anti-mouse	 and	 anti-rabbit	 antibodies	 (Thermo	 Fisher).	 Membranes	were	washed	 three	 times	 following	 secondary	 incubation.	 Signals	were	 visualized	using	enhanced	chemiluminescence	through	the	use	of	the	SuperSignal™	West	Pico	PLUS	 Substrate	 (Thermo	 Scientific).	 The	 film	 was	 scanned	 and	 quantification	relative	 to	 β-actin	was	 preformed	using	 ImageJ	 software	 and	 a	 student	 t-test	was	used	to	analyze	the	data.		
Immunocytochemistry			 Cells	were	seeded	onto	chambered	cell	culture	slides	(Corning)	and	grown	to	semi-confluency.	 	 The	 cells	 were	 then	 washed	 with	 sterile	 room	 temperature	phosphate	buffered	saline	(PBS	pH	7.4)	for	5	minutes	to	remove	culture	media.	Cells	were	 then	 fixed	with	 freshly	prepared	4%	paraformaldehyde	 for	10	minutes.	 	The	fixative	 was	 removed	 by	 washing	 three	 times	 using	 PBS	 and	 then	 the	 cells	 were	incubated	 in	 0.5%	 Triton	 X-100	 in	 PBS	 at	 RT	 for	 5	 minutes	 to	 permeabilize	 the	membranes.	 Slides	 were	 washed	 once	 again	 and	 incubated	 in	 5%	 Bovine	 Serum	Albumin	[BSA]	(	Fisher	Scientific).	Then	the	cells	were	incubated	overnight	at	4ºC	in	the	 primary	 antibody	 solution	 using	 BSA	 at	 a	 working	 dilution	 of	 1:200	 as	 per	manufacturer	 instructions.	 	 Slides	were	 then	washed	 as	 described	 previously	 and	incubated	in	flourochome-conjugated	secondary	antibody	solution	using	1%	BSA	at	
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a	 1:1000	 dilution	 for	 1	 hour	 at	 room	 temperature	 in	 the	 dark.	 	 Cells	 were	 then	washed	again	and	mounted	using	ProLong™	Gold	Antifade	with	DAPI	(Life)	to	stain	the	nucleus.	Imaging	was	performed	using	ZEN	2012	imaging	software	with	a	Zeiss	LS710	confocal	microscope.		
Antibodies	The	antibodies	used	in	these	studies	were,	Monoclonal	mouse	antibody	4B10	(1:10,000)	was	used	to	detect	hnRNPA1/A1;	polyclonal	rabbit	antibody		_	(1:10,000)	was	used	to	detect	hnRNP	A2/B1;	polyclonal	mouse	antibody		_	(1:10,000)	was	used	to	detect	hnRNP	K;	Monoclonal	mouse	antibody	BA3R	(1:5,000)	was	used	to	detect	Beta-Actin.					 	
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Results		Normal	 diploid	 cells	 have	 a	 finite	 number	 of	 cellular	 divisions.	 Once	 a	 cell	reaches	 it’s	 terminal	doubling	 time,	 it	will	 enter	 senescence	at	which	point	all	 cell	division	 is	 arrested	 but	 the	 cell	 maintain	 it’s	 metabolic	 activity.	 Through	 DNA	damage	 it	 is	 possible	 to	 induce	 a	 stress	 induced	 premature	 senescence	 (SIPS)	phenotype	in	young	cells.	In	the	following	set	of	studies,	we	used	150	uM	hydrogen	peroxide	to	induce	SIPS	in	vitro	(Frippiat,	Dewelle	et	al.	2002).	To	confirm	the	induction	of	stress	induced	premature	senescence	associated	ß-Galactosidase	(SA-ß-Gal)	in	culture	we	incubated	the	culture	in	X-Gal	solution	(5-bromo-4-chloro-3-indolyl-β-d-galactoside).	 This	 assay	 produces	 a	 blue	 precipitant	in	 senescent	 and	 SIPS	 cells	 after	 completion	 of	 the	 reaction	 due	 to	 the	 increased	lysosomal	β	galactosidase	production	(Campisi	and	Warner	2001).	Figure	2	below	shows	 (A)	 young,	 PDL	 19	 and	 (B)	 SIPS	 (pre-mature	 senescent),	 PDL	 19	 IMR-90	normal	human	fibroblast	cells	after	the	β	-Gal	assay.	The	premature	senescent	cells	show	an	increase	in	SA-	β	-Gal	activity	as	well	as	a	change	in	morphology.	The	pre-mature	 senescent	 cells	 are	 flatter	 and	 larger,	 similar	 to	 replicative	 senescent	 cells	when	compared	to	young	cells.			 	
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Young	Control	(PDL	19)		 													SIPS	(PDL	19)		 	Senescent	(PDL	65) 
C. 
	
Figure	2.	Senescent	and	SIPS	cells	exhibit	increased	β	–galactosidase	activity.	β	–galactosidase	assay	showing	young	control	H2O2,	treated	SIPS	cells,	and	replicative	senescent	cells.	Panel	A	shows	young	IMR-90	at	19	PDL	after	β-gal	assay	with	almost	absent	staining.	Panel	B	shows	premature	senescent	cells	at	19	PDL	after	treatment	with	hydrogen	peroxide	and	assayed	with	β-Gal.	Panel	C,	shows	replicative	senescent	cells	at	65	PDL	after	β–gal	assay.	Increased	blue	staining	shows	SA-β-Galactosidase	activity	at	neutral	pH	and	was	conducted	as	discussed	in	materials	and	methods	section.		 Next,	 the	 effect	 of	 hydrogen	 peroxide	 treatment	 on	 cell	 cycle	 arrest	 was	analyzed	using	single	color	FACS	(Figure	3).	This	assay	allows	 for	analysis	of	DNA	present	 in	 the	cell	using	FxCycle	Violet	dye.	 	Apoptotic	 cells	 that	have	 fragmented	DNA	will	have	less	signal	and	show	a	shift	to	the	left.	Cells	in	G0/G1	and	G2	appear	as	peaks	on	the	1D	FACS	with	cells	in	S	phase	seen	in	the	middle.	Cells	in	G0/1	and	G2	can	be	seen	as	separate	populations	because	before	S	phase	the	cell	content	is	2N	
A.	 B.	
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and	 after	 doubling	 of	 DNA	 becomes	 4N.	 This	 difference	 in	 DNA	 content	 can	 be	distinguished	by	the	varied	intensity	of	the	dye.	The	 cells	 treated	with	 hydrogen	peroxide	had	 a	much	 larger	 percentage	 of	cells	 arrested	 in	 G2,	 60%	 compared	 to	 22%	 in	 control,	 and	 a	 decrease	 in	 cells	 in	G0/G1	step,	21%	compared	to	66%	in	control.	In	addition	a	new	population	of	sub-G0	 apoptotic	 cells	 was	 observed	 in	 the	 premature	 senescent	 cells,	 approximately	8%.	
	
Figure	3.	SIPS	cells	arrest	
primarily	in	G2	(A)	Single	color	FACS	analysis	of	young	and	pre-mature	senescent	cells	using	Fx-Cycle	violet	stain	(Life).	Flow	cytometry	histogram	of	Pre-mature	senescent	cells	increased	G2	(60%)	and	Sub	G1	(8%)	population	accumulation.	 	
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Figure	4.	p21	expression	is	increased	in	senescent	and	SIPS	fibroblast	
cells.	The	western	blot	analysis	of	p21	(21	kDA)	compared	to	the	loading	control	beta-Actin	Loading	Control	[BA3R]	(42	kDa).	Replicative	 senescent	 cells	 are	 known	 to	have	 increased	 levels	 of	 cell	 cycle	regulators	 such	 as	 p21	 and	 p14ARF,	which	 are	 also	 cell	 cycle	 inhibitors	(Sharpless	and	DePinho	1999).	Premature	senescent	cells	have	also	been	reported	to	increase	levels	of	p21.	Figure	4	shows	premature	senescent	cells	to	have	an	increase	in	p21.	The	increased	expression	of	p21	may	be	the	reason	for	the	growth	arrest	observed	in	Figure	3.		Previous	studies	have	shown	that	replicative	senescent	cells	show	a	change	of	 sub	 cellular	 localization	 of	 hnRNP	 A1	 to	 the	 cytoplasm	 (Zhu,	 Xu	 et	 al.	 2002,	Shimada,	 Rios	 et	 al.	 2009,	 Ziaei,	 Shimada	 et	 al.	 2012).	 Immunocytochemistry	was	performed	in	young	and	pre-mature	senescent	IMR	90	cells	with	antibodies	specific	for	hnRNP	A1	and	hnRNP	A2	(Figure	5	A	&	B).	As	seen	by	the	co-localization	with	DAPI,	hnRNP	A1	and	A2,	remained	localized	in	the	nucleus	of	premature	senescent	cells	as	it	the	young	cells.		 Figure	 6	 shows	 that	 hnRNP	 A1	 is	 down	 regulated	 in	 premature	 senescent	cells	 about	 40%	 (p=.001).	 This	 is	 consistent	 with	 our	 previous	 studies	 where	
				Y						SIPS					S	
Beta-Actin 42	kDa P21 ~21kDA 
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replicative	senescent	cells	show	a	significant	down	regulation	(Zhu,	Xu	et	al.	2002).	Furthermore,	 we	 observed	 a	 decrease	 of	 about	 30%	 in	 hnRNP	 A2/B1	 levels	 in	premature	 senescent	 cells	 that	was	 significant	 (p=.04).	 Replicative	 senescent	 cells	show	a	significant	down	regulation	of	nearly	90%	(p=	.004)(Figure	7).			 To	 investigate	 the	 in	 vivo	 effect	 of	 cyclophosphamide	 and	 doxorubicin,	 a	known	 oxidant	 that	 causes	 oxidation	 of	 guanosine	 bases	 within	 the	 DNA,	 we	analyzed	the	 levels	of	hnRNP-A1	in	hippocampal	 lysates	 isolated	from	rats	treated	with	the	drug	combination	of	doxorubicin	and	cyclophosphamide.	The	expression	of	hnRNP	A1	 is	down	regulated	after	 treatment	about	30%	on	average,	however	 the	data	(p=.077)	was	not	statistically	significant	(Figure	8).	As	a	comparison	to	determine	specify,	we	measured	the	expression	of	hnRNP	K	 in	 cells	 treated	 with	 H2O2.	 We	 observed	 an	 increased	 expression	 following	hydrogen	peroxide	treatment	 in	premature	senescent	cells	(p<.05).	 In	addition	we	observed	 a	 slight	 increase	 of	 hnRNP	 expression	 in	 replicative	 senescent	 cells	(p<.05).	We	also	found	there	was	no	statistical	difference	in	the	expression	level	of	hnRNP	K	 in	 hippocampal	 lysates	 isolated	 from	 rats	 treated	with	 doxorubicin	 and	cyclophosphamide	cocktail	as	compared	to	saline	controls	(Figure	10).	
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B.																	
Figure	5.	The	nuclear	accumulation	of	hnRNP	A1	and	A2/B1	does	not	change	
in	 fibroblast	 cells.	 Young	 and	 pre-maturely	 senescent	 young	 IMR-90	 cells	 were	subjected	to	immunocytochemistry	and	probed	for	hnRNP	A1	expression.	DAPI	was	used	to	stain	the	nuclei.	Identical	fields	are	shown	for	DAPI	and	A.	hnRNP	A1	(4B10)	as	well	as	B.	hnRNP	A2/B1	fluorescent	signals.		40x	Magnification.	 	
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Figure	6.	hnRNP	A1	expression	is	decreased	in	SIPS	fibroblast	cells.		
A.	The	western	blot	analysis	of	hnRNP	A1	[4B10]	34-37	kDa	compared	to	the	loading	control	beta-Actin	Loading	Control	[BA3R]	42	kDa.	The	lanes	are	(Y)	young	PDL	19	cells	(N=4)	,	(SIPS)	H2O2	treated	cells	(N=4)	and	(S)replicative	senescent	cells(PDL	65).	B.	Expression	of	hnRNP	A1	controlled	for	loading	using	actin	and	plotted	relative	to	young	(PDL	19)	control	cells.	Error	bars	represent	the	standard	error	of	means.	 	
A.	
B.	
 
Beta-Actin 42	kDa hnRNP	A1 34-37	kDa 
		Y						SIPS						Y							SIPS							Y						SIPS						Y						SIPS							S	
Young	(PDL	19)	 	Pre-Mature	Senescent	(PDL	19)	
Re
la
ti
ve
	E
xp
re
ss
io
n	
Relative	expression	of	hnRNP	A1	
*	p=	0.001	
	 27	
	
	
	
Figure	7.	hnRNP	A2/B1	expression	is	decreased	in	SIPS	fibroblast	cells.	
	A.	The	western	blot	analysis	of	hnRNP	A2/B1	(34-37	kDa)	compared	to	the	loading	control	beta-Actin	Loading	Control	[BA3R]	42	kDa.	The	lanes	are	(Y)	young	PDL	19	cells	(N=4),	(SIPS)	H2O2	treated	cells	(N=4),	and	(S)	replicative	senescent	cells	(N=2),	right	to	left.	B.	Expression	of	hnRNP	A2/B1	controlled	for	loading	using	beta-Actin	and	plotted	relative	to	young	(PDL	19)	control	cells.	Error	bars	represent	the	standard	error	of	means.	 	
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Figure	8.	hnRNP	A1	expression	is	decreased	in	the	hippocampus	region	of	the	
brain	in	chemotherapy	treated	animals.	
	A.	The	western	blot	analysis	of	hippocampal	lysates	taken	from	rats	treated	with	doxorubicin	and	cyclophosphamide	and	control.	First	lane	shows	the	expression	of	hnRNP	A1	(34-37	kDa)	and	beta-actin	(42	kDa)	in	the	saline	control	(N=7)	and	the	second	lane	shows	the	chemotherapy	treated	animal	(N=8).		B.	Expression	of	hnRNP-A1	controlled	for	loading	using	actin	and	plotted	relative	to	saline	control	samples.	
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Figure	9.	hnRNP	K	expression	is	increased	in	SIPS	fibroblast	cells.		
A.	The	western	blot	analysis	of	hnRNP	K	(34-37	kDa)	compared	to	the	loading	control	beta-Actin	Loading	Control	[BA3R]	42	kDa.	The	lanes	are	young	PDL	19	cells	(N=4)	,	SIPS	H2O2	treated	cells	(N=4),	and	replicative	senescent	cells	(N=2),	right	to	left.	B.	Expression	of	hnRNP	A2/B1	controlled	for	loading	using	beta-Actin	and	plotted	relative	to	young	(PDL	19)	control	cells.	Error	bars	represent	the	standard	error	of	means.		 	
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Figure	10.	A.	The	western	blot	analysis	of	hippocampal	lysates	taken	from	rats	treated	with	doxorubicin	and	cyclophosphamide	and	control.	First	two	lanes	show	the	expression	of	hnRNP-K	(66kDa)	and	beta-actin	(42	kDa)	in	the	saline	control	animal	(N=7)	and	the	second	two	lanes	show	the	chemotherapy	treated	animal	(N=9),	left	to	right.	Bands	shown	are	representative	of	the	population.	B.	Expression	of	hnRNP-K	controlled	for	loading	using	actin	and	plotted	relative	to	saline	control	samples.	Error	bars	represent	the	standard	error	of	means.		 	
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Discussion		 The	 multitude	 of	 genes	 responsible	 for	 replicative	 cell	 senescence	modulation	via	various	forms	of	mRNA	processing	is	yet	to	be	fully	elucidated.	The	expression	of	hnRNP	A1	and	A2	has	been	previously	shown	to	be	important	during	replicative	senescence.	hnRNPA1	and	A2	show	a	decreased	expression	in	replicative	senescent	normal	human	diploid	 fibroblast	 cells	 (Zhu,	Xu	et	al.	2002).	 In	addition,	the	 overexpression	 of	 hnRNPA1	 and	 A2	 resulted	 in	 a	 higher	 ratio	 of	 p14ARF	compared	 to	p16INK4a	due	 to	a	 change	 in	 the	alternative	 splice	decisions	and	exon	skipping	 (Zhu,	 Xu	 et	 al.	 2002).	 This	 indicated	 that	 the	 replicative	 senescent	phenotype	 is	 potentially	 maintained	 by	 alterations	 in	 the	 posttranscriptional	processing	of	the	mRNA.	Replicative	 senescence	 has	 been	 hypothesized	 to	 be	 a	 result	 of	 oxidative	stress.	While	it	is	known	that	telomere	shortening	is	one	of	the	main	causes	for	the	induction	of	 replicative	 senescence,	 it	 has	been	hypothesized	 that	oxidative	 stress	may	 also	 be	 a	 major	 contributing	 factor	 (Colavitti	 and	 Finkel	 2005).	 It	 has	 been	suggested	 that	 intracellular	 reactive	 oxygen	 species	 play	 a	 role	 as	 signaling	molecules	 and	 oxidized	 macromolecules	 mediate	 the	 senescent	 phenotype.	(Colavitti	and	Finkel	2005)	It	 is	 of	 interest	 to	 determine	 whether	 the	 stress	 induced	 premature	senescence	 (SIPS)	 caused	by	ROS	 can	modulate	hnRNPA1	gene	 expression	 as	 this	form	of	senescence	has	physiological	relevance.	Here	we	show	that	hnRNPA1	is	not	
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regulated	by	oxidative	stress	induced	premature	senescence	at	the	same	magnitude	as	it	is	in	replicative	senescence.		We	 have	 shown	 that	 hydrogen	 peroxide	 can	 induce	 the	 pH	 neutral	senescence	 associated	 biomarker	 β-galactosidase	 (SA	 β-gal)	 (Figure	 2)	 as	 well	 as	growth	 arrest	 in	 human	 fibroblast;	 similar	 to	 what	 has	 been	 observed	 by	 others	(Dimri,	Lee	et	al.	1995,	Zhou,	Chen	et	al.	2015).		Furthermore,	we	have	shown	that	H2O2	treated	fibroblast	cells	exhibit	a	shift	towards	G2	stage	of	the	cell	cycle	(Figure	3).	ROS	mediated	DNA	damage	can	cause	G2/M	 cell	 cycle	 arrests	 via	 the	 p53	 and	 ChK1	 parallel	 pathways(Guo,	 Wu	 et	 al.	2014).		The	increase	of	cells	in	G2	stage	is	likely	because	of	the	inactivation	of	Cdc25	and	Cdc2	by	Chk1,	 resulting	 in	cellular	arrest	 (Bucher	and	Britten	2008).	 	A	small	population	of	the	H2O2	treated	cells	also	transitioned	into	hypodiploid	sub-G0	stage,	with	 less	 then	 2N	 DNA	 content.	 	These	 cells	 are	 in	 the	 process	 of	 apoptosis	 both	mitochondrial	 and	 extrinsic	 pathways	 after	 being	 arrested	 in	 G2/M	 for	 too	 long	(DiPaola	2002).	hnRNPs	 shuttle	 between	 the	 nucleus	 and	 cytoplasm	 continuously	 in	 young	proliferating	 cells,	 however	 during	 replicative	 senescence	 hnRNP	 A1	 and	 A2	accumulate	to	the	cytoplasm.	This	change	in	localization	has	been	attributed	to	the	increase	 of	 p-38	MAPK	 (Shimada,	 Rios	 et	 al.	 2009).	Here	we	 show	 that	H2O2	SIPS	cells	do	not	 share	 the	same	change	 in	 localization	pattern	of	hnRNP	A1	and	A2	 in	senescent	cells	(Figure	5).	The	two	hnRNPs	remained	at	high	levels	in	the	nucleus	in	both	SIPS	and	control	 cells.	Activation	of	p-38	MAPK	can	be	 induced	by	ROS	 from	
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exogenous	 sources	 such	 as	 H2O2,	 however	 hnRNP	 A1	 and	 A2	 localization	 pattern	may	not	driven	by	increased	levels	of	p-38	MAPK	alone	in	SIPS	cells		 We	have	proposed	that	the	maintenance	of	replicative	senescence	is	in	part	regulated	by	hnRNP	A1	and	A2	(Zhu,	Xu	et	al.	2002,	Ziaei,	Shimada	et	al.	2012)	.	This	may	be	due	to	a	decrease	of	hnRNP	A1	and	A2	in	senescent	cells	altering	the	levels	of	 expression	 of	 target	 genes	 during	 senescence.	 	 This	 was	 supported	 by	 the	increase	of	growth	inhibitors	and	f-actin	in	siRNA	known	down	of	hnRNP	A	and	A2	cultures	(Zhu,	Xu	et	al.	2002,	Shimada,	Rios	et	al.	2009).		Western	blot	analyses	showed	that	the	levels	of	hnRNP	A1	(Figure	6)	as	well	as	 hnRNP	 A2/B1	 (Figure	 7)	 decreased	 in	 SIPS	 cells,	 when	 compared	 to	 control	(Figure	 7).	 hnRNP	 A2/B1	 are	 a	 close	 cousin	 to	 hnRNP	 A1	 with	 over	 80%	 of	conserved	 of	 amino	 acids	 (Dreyfuss,	 Matunis	 et	 al.	 1993).	 This	 is	 especially	interesting	since	hnRNP	A2/B1	expression	is	increased	in	the	dendrites	and	soma	as	a	 result	 of	 neuronal	 activity	 and	 brain	 derived	 neurotropic	 factor	 	 (BDNF)	 (Leal,	Afonso	et	al.	2014).			 Interestingly,	 we	 observed	 an	 upregulation	 of	 hnRNP	 K	 in	 premature	senescent	 cells	 (Figure	 9).	 hnRNP-K	 is	 a	 p53	 co-activator	 and	 plays	 a	 role	 in	activating	 the	 p21	 cell	 cycle	 regulator.	 Other	 groups	 have	 also	 observed	 this	increase	in	expression	of	hnRNP	K	after	DNA	damage	due	to	UV	radiation	(Moumen,	Masterson	 et	 al.	 2005)	 and	 also	 in	 tumorigenic	 cells	 (Gao,	 Yu	 et	 al.	 2013).	 	 Thus,	hnRNP	K	may	play	a	role	in	the	DNA	damage	response.			 Given	that	we	know	that	hnRNP	A1	can	modulate	the	levels	of	p21	in	hnRNP	A1	siRNA	knockdown	senescent	models	(Shimada,	Rios	et	al.	2009)	,	it	is	of	interest	
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to	 determine	 whether	 hnRNP	 K	 can	 also	 paly	 a	 role	 in	 p21	 expression	 and	senescence.		The	anthracycline	doxorubicin	is	a	known	oxidative	stress-causing	source	of	ROS	 that	 can	 cause	 the	 initiation	 of	 apoptosis	 at	 sub	 lethal	 concentrations.	 	 In	addition	 it	 is	a	popular	antineoplastic	agent	used	 in	chemotherapy	 to	 treat	a	wide	range	 of	 cancers	 (Thorn,	 Oshiro	 et	 al.	 2011).	 Recently,	 we	 have	 shown	 rodents	exhibit	 a	 cognitive	 impairment	 post-treatment	 with	 doxorubicin	 and	cyclophosphamide	 (Salas-Ramirez	 et	 al.,	 2015).	 In	 addition	 it	 has	 been	 suggested	cancer	survivors	suffer	 from	cognitive	dysfunction	(Ahles	and	Root	2018).	Despite	limited	access	to	the	brain,	doxorubicin	causes	a	system	inflammatory	response	and	oxidative	 stress.	 Our	 data	 has	 shown	 that	 hnRNP	 A1,	 is	 down	 regulated	 in	chemotherapy	 treated	 rats.	 Despite	 the	 low	 statistical	 power,	 we	 observed	 a	constant	 decrease	 across	 all	 animals	 at	 varied	 levels.	 This	may	 suggest	 a	 possible	mechanism	 that	 is	 yet	 to	 be	 elucidated	 in	 which	 hnRNPs	 in	 part	 modulate	 the	cognitive	impairment.	It	has	been	shown	that	synaptic	activity	increases	hnRNPs	in	the	 dendrites	 and	 synapses	 via	 a	 Brain-derived	 neurotrophic	 factor	 (BDNF)	dependent	mechanism	(Leal,	Afonso	et	al.	2014).		
Conclusions		An	 understanding	 of	 cellular	 responses	 to	 ROS	 from	 stressors	 such	 as	hydrogen	peroxide,	ultra	violet	radiation	and	chemotherapeutic	agents	will	provide	a	 better	 understanding	 of	 ageing	 as	 well	 as	 age-related	 pathogenesis.	 	 Little	 is	known	about	the	molecular	mechanisms	of	SIPS	caused	by	ROS	and	much	still	needs	to	be	characterized.	 	We	have	shown	here	that	hnRNP	A1	is	not	modulated	in	SIPS	
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by	 the	 same	 mechanism	 as	 replicative	 senescence.	 We	 observed	 a	 decrease	 in	expression	of	 hnRNP	A1	and	A2/B1	 in	hydrogen	peroxide	 treated	 fibroblast	 cells,	however	 the	 localization	 pattern	 has	 not	 changed	 when	 compared	 to	 control.	 In	addition,	 animals	 treated	 with	 doxorubicin	 and	 cyclophosphamide	 did	 show	 a	decrease	 in	 hnRNP	 A1	 in	 the	 hippocampus.	 This	 may	 suggest	 a	 function	 of	premature	 senescence	 in	 the	 brain	 that	 may	 contribute	 to	 the	 chemotherapy	induced	cognitive	dysfunction	experienced	by	the	rats.		
Future	Direction			 The	presence	of	senescent	cells	is	a	double-edged	sword,	by	providing	tumor	suppression	and	wound	healing	early	in	life	and	switching	roles	later	in	life	by	accumulating	and	expressing	the	secretory	phenotype.	Currently	a	perfect	marker	for	cellular	senescence	does	not	exist,	and	we	rely	on	a	combination	of	marker	to	identify	cellular	senescence.	In	this	paper	we	investigated	possible	hnRNPs	that	may	have	a	role	in	modulating	stress	induced	premature	senescence	that	showed	promise	as	modulators	of	replicative	senescence.		Premature	senescence	is	potentially	a	more	physiologically	relevant	phenotype,	as	it	is	induced	by	both	extrinsic	(e.g.	chemotherapy)	and	intrinsic	(e.g.	mitochondria	metabolism)	genotoxic	factors.	Future	studies	will	focus	on	identifying	the	common	factors	that	modulate	both	premature	and	replicative	senescence	in	hope	to	eliminate	cells	with	senescence	associated	secretory	phenotype.		
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Figure	11.	The	number	of	hnRNP	A1	and	A2	positive	cells	is	lower	in	the	
hippocampus	region	of	the	brain	in	chemotherapy	treated	animals.	Doxorubicin	and	cyclophosphamide	treated	rats	had	their	brains	resected	and	sliced	into	30	micron	slices.	Immunohistochemistry	staining	using	DAB	probed	for	hnRNP	A1	(A)	and	hnRNP	A2/B1	(B)	showing	the	hippocampal	regions	CA1,	DG	and	CA3	at	100x	magnification.				 	
	 CA1		 							DG	 	 				CA3	 
Saline 
Chemo
 
	 CA1		 					DG	 	 		CA3	 
 
Saline 
Chemo
 
hnRNP	A2/B1	
hnRNP	A1	
A	
	 37	
Future	 studies	 will	 investigate	 the	 biological	 markers	 including	 hnRNP	expression	 in	 the	 senescence-accelerated	mouse	 (SAMP8).	 SAMP8	 exhibits	 higher	levels	of	senescent	cells,	increased	oxidative	stress	in	the	brain,	and	has	been	used	as	 a	 model	 for	 a	 number	 of	 neurodegenerative	 diseases	 (Butterfield	 and	 Poon	2005).	 In	addition	the	 increase	 in	hnRNP	K	 in	premature	senescent	cells	may	be	a	novel	way	in	which	senescence	is	modulated.	To	investigate	further	we	will	utilize	siRNA	and	conditional	knockdown	models	to	decrease	or	eliminate	hnRNP	K.	Furthermore,	 preliminary	 immunohistochemistry	 data	 using	 DAB	 staining	shows	 a	 decreased	 expression	 and	 hnRNP	 A1	 and	 A2/B1	 positive	 cells	 in	 the	hippocampus	 of	 doxorubicin	 and	 cyclophosphamide	 treated	 rats	 (Figure	 11).	 To	investigate	further,	we	will	investigate	the	localization	and	signal	intensity	of	hnRNP	A1,	 A2/B1	 and	 K	 in	 the	 hippocampus	 of	 chemotherapy	 treated	 rats	 to	 elucidate	whether	premature	senescence	in	the	hippocampus	may	play	a	role	in	the	cognitive	dysfunction	observed	by	Salas-Ramirez,	Bagnall	et	al.	(2015).			 	
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